Sources of the figures for Jordan
| Source | Type | Rows | Indicators | Years | Read from | Retrieved |
|---|---|---|---|---|---|---|
| UNAIDS AIDSinfo | Modelled estimate | 552 | 19 | 2000–2024 | aidsinfo.unaids.org | 2026-10-20 |
| WHO Global Tuberculosis Programme | Programme record | 151 | 16 | 2000–2025 | extranet.who.int | 2026-10-16 |
| World Bank Open Data | Modelled estimate | 51 | 2 | 2000–2025 | api.worldbank.org | 2026-10-12 |
| IATI, through d-portal | Expenditure account | 40 | 3 | 2003–2026 | d-portal.org | 2026-10-12 |
| OECD Creditor Reporting System | Expenditure account | 39 | 3 | 2003–2024 | sdmx.oecd.org | 2026-10-12 |
| ForeignAssistance.gov | Expenditure account | 24 | 3 | 2009–2020 | foreignassistance.gov | 2026-10-29 |
| Demographic and Health Surveys | Survey | 15 | 1 | 2017–2023 | api.dhsprogram.com | 2026-10-16 |
| WHO HIV testing services dashboard | Programme record | 9 | 5 | 2018–2019 | eic-database-290813.ew.r.appspot.com | 2026-10-14 |
Indicators held
| Indicator | Domain | Unit | Rows | Years | Sources | Most recent value |
|---|---|---|---|---|---|---|
| Actual expenditure on collaborative TB/HIV activities | Financing | USD | 7 | 2017–2024 | WHO Global Tuberculosis Programme | $0 (2024) |
| Budget required for collaborative TB/HIV activities | Financing | USD | 8 | 2018–2025 | WHO Global Tuberculosis Programme | $10k (2025) |
| Country-reported HIV expenditure, all sources | Financing | USD | 2 | 2012–2013 | UNAIDS AIDSinfo | $1.1m (2013) |
| Domestic funding received by the national TB programme | Financing | USD | 6 | 2017–2023 | WHO Global Tuberculosis Programme | $1.2m (2023) |
| Expected Global Fund funding for the national TB programme | Financing | USD | 8 | 2018–2025 | WHO Global Tuberculosis Programme | $738k (2025) |
| Expected USAID funding for the national TB programme | Financing | USD | 5 | 2018–2022 | WHO Global Tuberculosis Programme | $0 (2022) |
| Expected domestic funding for the national TB programme | Financing | USD | 8 | 2018–2025 | WHO Global Tuberculosis Programme | $1.5m (2025) |
| Expected funding for collaborative TB/HIV activities | Financing | USD | 7 | 2018–2025 | WHO Global Tuberculosis Programme | $1k (2025) |
| External HIV financing (all donors, ODA) | Financing | USD | 19 | 2003–2024 | OECD Creditor Reporting System | $108k (2024) |
| External HIV financing from governments other than the United States (IATI) | Financing | USD | 19 | 2003–2025 | IATI, through d-portal | $116k (2025) |
| External HIV financing from multilateral bodies other than the Global Fund (IATI) | Financing | USD | 9 | 2012–2026 | IATI, through d-portal | $6k (2026) |
| External HIV financing from the United States (ODA) | Financing | USD | 19 | 2008–2020 | ForeignAssistance.gov, OECD Creditor Reporting System | $42k (2020) |
| Funding received for collaborative TB/HIV activities | Financing | USD | 7 | 2017–2024 | WHO Global Tuberculosis Programme | $5k (2024) |
| Global Fund HIV disbursements to the country | Financing | USD | 23 | 2003–2015 | IATI, through d-portal, OECD Creditor Reporting System | $33k (2015) |
| Global Fund funding received by the national TB programme | Financing | USD | 8 | 2017–2024 | WHO Global Tuberculosis Programme | $1.1m (2024) |
| US HIV disbursements managed by USAID | Financing | USD | 9 | 2009–2020 | ForeignAssistance.gov | $341k (2020) |
| US HIV disbursements managed by other US agencies | Financing | USD | 5 | 2009–2014 | ForeignAssistance.gov | $0 (2014) |
| USAID funding received by the national TB programme | Financing | USD | 4 | 2017–2020 | WHO Global Tuberculosis Programme | $0 (2020) |
| % of ALL PLHIV who are virally suppressed | Treatment cascade | percent | 14 | 2010–2024 | UNAIDS AIDSinfo | 62.0% (2024) |
| % of PLHIV on ART (second 95, PLHIV base) | Treatment cascade | percent | 15 | 2010–2024 | UNAIDS AIDSinfo | 64.0% (2024) |
| % of PLHIV who have been diagnosed (first 95) | Treatment cascade | percent | 15 | 2010–2024 | UNAIDS AIDSinfo | 84.0% (2024) |
| % of estimated HIV-positive incident TB cases on TB treatment and ART | Treatment cascade | percent | 11 | 2003–2024 | UNAIDS AIDSinfo | 57.1% (2024) |
| % of people newly enrolled in HIV treatment diagnosed with TB disease | Treatment cascade | percent | 2 | 2015–2019 | UNAIDS AIDSinfo | 3.0% (2019) |
| % of people newly enrolled in HIV treatment started on TB preventive therapy | Treatment cascade | percent | 1 | 2015 | UNAIDS AIDSinfo | 0.1% (2015) |
| % of returned HIV test results that were positive | Treatment cascade | percent | 1 | 2018 | WHO HIV testing services dashboard | 0.0% (2018) |
| HIV self-test kits distributed | Treatment cascade | count | 1 | 2018 | WHO HIV testing services dashboard | 1,000 (2018) |
| HIV tests performed at a health facility | Treatment cascade | count | 2 | 2018–2019 | WHO HIV testing services dashboard | 1,130 (2019) |
| HIV tests performed through community outreach | Treatment cascade | count | 1 | 2018 | WHO HIV testing services dashboard | 1,000 (2018) |
| HIV tests performed with the result returned to the person | Treatment cascade | count | 5 | 2018–2019 | UNAIDS AIDSinfo, WHO HIV testing services dashboard | 200 (2019) |
| HIV-exposed infants tested within two months of birth | Treatment cascade | percent | 3 | 2013–2019 | UNAIDS AIDSinfo | 42.0% (2019) |
| HIV-positive TB patients started or continued on ART | Treatment cascade | count | 10 | 2015–2024 | WHO Global Tuberculosis Programme | 1 (2024) |
| New HIV diagnoses with a CD4 count below 200 | Treatment cascade | percent | 5 | 2015–2020 | UNAIDS AIDSinfo | 20.0% (2020) |
| Number of people on ART (PEPFAR MER TX_CURR) | Treatment cascade | count | 15 | 2010–2024 | UNAIDS AIDSinfo | 500 (2024) |
| People newly enrolled on ART during the year | Treatment cascade | count | 3 | 2015–2020 | WHO Global Tuberculosis Programme | 0 (2020) |
| Pregnant women with HIV who received ARVs for PMTCT | Treatment cascade | count | 15 | 2010–2024 | UNAIDS AIDSinfo | 3 (2024) |
| TB patients recorded as HIV-positive | Treatment cascade | count | 10 | 2015–2024 | WHO Global Tuberculosis Programme | 1 (2024) |
| TB patients with an HIV test result recorded | Treatment cascade | count | 10 | 2015–2024 | WHO Global Tuberculosis Programme | 230 (2024) |
| AIDS-related deaths | Epidemic estimates | count | 125 | 2000–2024 | UNAIDS AIDSinfo | 100 (2024) |
| Deaths from TB among people living with HIV | Epidemic estimates | count | 50 | 2000–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 1 (2024) |
| HIV prevalence among a key population | Epidemic estimates | percent | 3 | 2024 | UNAIDS AIDSinfo | By population group, sex or age only, to 2024 |
| HIV prevalence, ages 15-49 | Epidemic estimates | percent | 50 | 2000–2024 | UNAIDS AIDSinfo, World Bank Open Data | 0.1% (2024) |
| Incident TB cases among people living with HIV | Epidemic estimates | count | 50 | 2000–2024 | UNAIDS AIDSinfo, WHO Global Tuberculosis Programme | 2 (2024) |
| New HIV infections | Epidemic estimates | count | 125 | 2000–2024 | UNAIDS AIDSinfo | 100 (2024) |
| People living with HIV | Epidemic estimates | count | 125 | 2000–2024 | UNAIDS AIDSinfo | 680 (2024) |
| People with comprehensive correct knowledge of HIV (household survey) | Prevention and outreach | percent | 15 | 2017–2023 | Demographic and Health Surveys | By population group, sex or age only, to 2023 |
| Total population | Population denominators | count | 26 | 2000–2025 | World Bank Open Data | 11,520,684 (2025) |
Every row shown on the Jordan page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.
Turn your phone to read the chart upright